87 related articles for article (PubMed ID: 22648779)
1. Monitoring for potential adverse effects of prenatal gene therapy: mouse models for developmental aberrations and inadvertent germ line transmission.
Coutelle C; Waddington SN; Themis M
Methods Mol Biol; 2012; 891():329-40. PubMed ID: 22648779
[TBL] [Abstract][Full Text] [Related]
2. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
Themis M
Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780
[TBL] [Abstract][Full Text] [Related]
3. Monitoring for potential adverse effects of prenatal gene therapy: use of large animal models with relevance to human application.
Mehta V; Abi-Nader KN; Carr D; Wallace J; Coutelle C; Waddington SN; Peebles D; David AL
Methods Mol Biol; 2012; 891():291-328. PubMed ID: 22648778
[TBL] [Abstract][Full Text] [Related]
4. No evidence of germ-line transmission by adenovirus-mediated gene transfer to mouse testes.
Kojima Y; Hayashi Y; Kurokawa S; Mizuno K; Sasaki S; Kohri K
Fertil Steril; 2008 May; 89(5 Suppl):1448-54. PubMed ID: 17624347
[TBL] [Abstract][Full Text] [Related]
5. No evidence for germ-line transmission following prenatal and early postnatal AAV-mediated gene delivery.
Jakob M; Mühle C; Park J; Weiss S; Waddington S; Schneider H
J Gene Med; 2005 May; 7(5):630-7. PubMed ID: 15693035
[TBL] [Abstract][Full Text] [Related]
6. Male germ-line cells are at risk following direct-injection retroviral-mediated gene transfer in utero.
Porada CD; Park PJ; Tellez J; Ozturk F; Glimp HA; Almeida-Porada G; Zanjani ED
Mol Ther; 2005 Oct; 12(4):754-62. PubMed ID: 16084775
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B.
Schneider H; Adebakin S; Themis M; Cook T; Douar AM; Pavirani A; Coutelle C
J Gene Med; 1999; 1(6):424-32. PubMed ID: 10753068
[TBL] [Abstract][Full Text] [Related]
8. Animal models for prenatal gene therapy: the sheep model.
Abi-Nader KN; Boyd M; Flake AW; Mehta V; Peebles D; David AL
Methods Mol Biol; 2012; 891():219-48. PubMed ID: 22648775
[TBL] [Abstract][Full Text] [Related]
9. On the scientific and ethical issues of fetal somatic gene therapy.
Coutelle C; Rodeck C
Gene Ther; 2002 Jun; 9(11):670-3. PubMed ID: 12032684
[TBL] [Abstract][Full Text] [Related]
10. Efficient gene-driven germ-line point mutagenesis of C57BL/6J mice.
Michaud EJ; Culiat CT; Klebig ML; Barker PE; Cain KT; Carpenter DJ; Easter LL; Foster CM; Gardner AW; Guo ZY; Houser KJ; Hughes LA; Kerley MK; Liu Z; Olszewski RE; Pinn I; Shaw GD; Shinpock SG; Wymore AM; Rinchik EM; Johnson DK
BMC Genomics; 2005 Nov; 6():164. PubMed ID: 16300676
[TBL] [Abstract][Full Text] [Related]
11. Animal models for prenatal gene therapy: the nonhuman primate model.
Mattar CN; Biswas A; Choolani M; Chan JK
Methods Mol Biol; 2012; 891():249-71. PubMed ID: 22648776
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy progress and prospects: fetal gene therapy--first proofs of concept--some adverse effects.
Coutelle C; Themis M; Waddington SN; Buckley SM; Gregory LG; Nivsarkar MS; David AL; Peebles D; Weisz B; Rodeck C
Gene Ther; 2005 Nov; 12(22):1601-7. PubMed ID: 16136161
[TBL] [Abstract][Full Text] [Related]
13. Developmental stage- and germ cell-regulated expression of a calcium-binding protein mRNA in mouse Sertoli cells.
Kraszucka K; Burfeind P; Nayernia K; Köhler M; Schmid M; Yaylaoglu M; Engel W
Mol Reprod Dev; 1999 Nov; 54(3):232-43. PubMed ID: 10497345
[TBL] [Abstract][Full Text] [Related]
14. The concept of prenatal gene therapy.
Coutelle C; Waddington SN
Methods Mol Biol; 2012; 891():1-7. PubMed ID: 22648765
[TBL] [Abstract][Full Text] [Related]
15. Possible mechanism of gene transfer into early to mid-gestational mouse fetuses by tail vein injection.
Kikuchi N; Nakamura S; Ohtsuka M; Kimura M; Sato M
Gene Ther; 2002 Nov; 9(22):1529-41. PubMed ID: 12407425
[TBL] [Abstract][Full Text] [Related]
16. Animal models for prenatal gene therapy: rodent models for prenatal gene therapy.
Roybal JL; Endo M; Buckley SM; Herbert BR; Waddington SN; Flake AW
Methods Mol Biol; 2012; 891():201-18. PubMed ID: 22648774
[TBL] [Abstract][Full Text] [Related]
17. Animal models for prenatal gene therapy: choosing the right model.
Mehta V; Peebles D; David AL
Methods Mol Biol; 2012; 891():183-200. PubMed ID: 22648773
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of a mouse testicular olfactory receptor and its role in chemosensing and in regulation of sperm motility.
Fukuda N; Yomogida K; Okabe M; Touhara K
J Cell Sci; 2004 Nov; 117(Pt 24):5835-45. PubMed ID: 15522887
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated in utero gene transfer in mice and guinea pigs: tissue distribution of recombinant adenovirus determined by quantitative TaqMan-polymerase chain reaction assay.
Senoo M; Matsubara Y; Fujii K; Nagasaki Y; Hiratsuka M; Kure S; Uehara S; Okamura K; Yajima A; Narisawa K
Mol Genet Metab; 2000 Apr; 69(4):269-76. PubMed ID: 10870844
[TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
